Current Commitments

Director

Hanuman Medical LLC
PlasmaSeal LLC
Cerco Medical LLC

Officer

President, Hanuman Medical
President, PlasmaSeal
President, Cerco Medical
Building Committee Convener, St. Gregory of Nyssa Church, San Francisco, CA

Advisor

Diabetes Interview, San Francisco, CA
Monkey Matters, Moraga, CA.

Current For-profit Employment

1/98-present Hanuman Medical. President. In partnership with Randy Dorian, medical breakthroughs in a happy setting.

1/95-present Cerco Medical. President. A new venture to develop use of thin sheet immunoisolated islet transplants (bio-artificial pancreas). Principal advisor is Prof. Richard Bergman, U.S.C. Responsible for all executive, financial and intellectual property functions.

1/95-present PlasmaSeal President. A venture to develop devices to prepare from patient blood stat autologous plasma concentrate useful when gelled for many surgical applications to stop bleeding and to adhere tissues. Prototypes rapidly prepare effective sealants with properties superior to those of any fibrin sealant on the market. The projected market for tissue sealants or devices to make autologous tissue sealants is over $200 million in the United States and $400 million worldwide. Worldwide rights recently licensed to major multinational health care company. Responsible for all executive, financial and intellectual property functions.

Past For-profit Work Accomplishments

5/93-1/97 Avmax, Inc. Consultant to Founder. A venture to improve bioavailability of oral pharmaceuticals. Founder is Prof. Leslie Z. Benet, Chairman of the Department of Pharmacy at the University of California-San Francisco. Wrote business plan.

3/94-1/95 PlasmaSeal Corporation Vice-president.

6/92-1/95 Chemtrix, Inc. Consultant. A venture to develop methods for noninvasive measurement of blood glucose.

11/91-9/93 Metabolex, Inc. Vice President, Technology Management. Metabolex performs research and development to discover new therapies for insulin resistance diseases. Resigned September, 1993. Cofounders are Thomas Glaze, Prof. Jerrold Olefsky (UCSD), and William Usinger.

8/89-9/93 Transtech Medical, Inc. Vice President, Technology Management and Director. Transtech was founded to develop and commercialize research in tissue and organ transplantation without the use of immunosuppression. Resigned as Director and VP September, 1993. Cofounders are Prof. Kent Cochrum (UC-Davis) and Jere Goyan (UC-San Francisco). $500,000 seed financing in October, 1989. Wrote business plan.

4/89-7/91 Thymax Corporation. Director of Theoretical Biology, President and Director. Thymax Corporation was a research and development company whose efforts were focused on a new immune system diagnostic and on producing new therapies for Type II diabetes. Cofounders are Robert Gross, MD, Dr. William Anhalt. $275,000 seed financing May, 1989. Resigned as director in August, 1991. Thymax filed for bankruptcy in December, 1991, and was liquidated in 1992.

3/88-5/90 Paravax, Inc. Director. A venture to develop new vaccines for the prevention of parasitic diseases concentrating on vaccines for companion animals. Cofounders are Lynnor Stevenson, and Prof. Robert Grieve (Colorado State University). Went public in 1997 under the name Heska Corporation (HSKA).

9/86-12/89 Venture Investment Analysis. Sole Proprietor. Analysis of the scientific, technical, commercial and market opportunity for ventures in biological and medical technology. Clients included Kleiner, Perkins, Caufield & Byers, New Enterprise Associates, Montgomery Medical Ventures, Charter Venture Management, Oak Investment Management, MIP Equity Fund, Columbine Ventures, Brunswick Corporation, The University of California, Verax Corporation and Health Craft International.

9/88-1/89 Thomas Research Corporation, Hayward, California. A venture to develop novel therapeutics based on trace element metabolism. Founder is Thomas Nufert. Served as Director and briefly as President. Worked to develop TRC's strategic plan. Left company over disagreement with founder about acquisition of technology.

10/87-3/88 Bio 2000, Palo Alto, California. Consultant. A venture to develop new prognostic and diagnostic tests and new prophylactic and therapeutic products for autoimmune disease. The first products are for detection and treatment of diabetes. Founders are Hugh McDevitt, Ken Melmon, Gary Fathman and Steve Brandt of Stanford University. Wrote business plan and participated in strategic planning. Company was merged into Immulogics, Cambridge, Massachusetts.

6/83-5/86 Montgomery Securities, San Francisco, California. Senior Biotechnology Analyst. Member of Health Care Group. Primary responsibility for publicly held medical technology stocks, foreign biological technology stocks and selected major drug companies. Did respected research on impact of genetic engineering and biotechnology on the health care industry.

9/82-6/83 The Remora Fund, Palo Alto, California. General Partner. A fund specializing in medical seed and venture investments.

1/80-8/82 F. Eberstadt & Co., Inc., New York, NY. Vice President, Research Division. Research responsibilities in corporate finance and venture capital. Wrote many studies of industry and leading biotechnology companies. First biotechnology analyst on Wall Street.

Not-for-profit Work

7/94--6/97 Vestry, St. Gregory's Church. Elected by membership July, 1994 Vestry of St. Gregory's is responsible for monthly management of the church's life. St. Gregory's itself is a new community devoted to liturgical renewal. Our mission statement is, "St. Gregory's Church invites people to see God's image in all humankind, to sing and to dance to Jesus' lead, and to become God's friends."

6/86--present Building for St. Gregory's Church on Potrero Hill. Convener of building committee for 500 DeHaro Street (at Mariposa Street); responsible for design, fund raising and construction. Worship space for 200; education, music and meeting rooms; parking; offices. Building occupied October, 1995. Dedicated by Rt. Rev. William Swing, Bishop of California, October 23, 1995. Design by Goldman Architects, San Francisco.

Educational Degrees

1977-1978 MA Chemistry, Harvard University, Cambridge, Massachusetts 02139 Advisor: Professor Jeremy Knowles
1973-1977 S.B. Chemistry, The College of The University of Chicago, Chicago, Illinois 60637 Research Advisor: Professor Leon Stock
1970-1973 Maine Township High School South, Park Ridge, Illinois 60068

Honors and Awards

1989 Art Deco Restoration Award of the Art Deco Society of California.
1986 Runner-up for All American Team in Institutional Investor Research Analyst Poll (Biotechnology Analyst).
1977 Phi Beta Kappa ( of Illinois).
1977 Graduation with honors, The College, The University of Chicago.
1977 Howell Murray -- Alumni Association Award, The College, The University of Chicago.
1977 National Science Foundation Fellowship.
1977 Sigma Xi Certificate of Merit and Award for Excellence in Undergraduate Scientific Research, The College, The University of Chicago.
1977 Outstanding Senior, Chemistry Department, The College, The University of Chicago.
1976 Maroon Key, The College, The University of Chicago.
1976 Student Aide, The College, The University of Chicago.
1973 Graduated high school class of 851 eleventh highest grade point average.
1970 Eagle Scout.